HIV. Gynecological diseases
Conditions
Interventions
Prospective, observational study in which 100 trans men using masculinizing hormones will be followed for a year with half-yearly visits. The main objective is the elaboration of a guide containing pr
Behavioural
F64.1
Sponsors
Mauro Schechter
Projeto Praça Onze
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: female gender (at birth); Able to provide written informed consent;Aged 18 to 65 years older; Identify with the male Use of masculinizing hormones
Exclusion criteria
Exclusion criteria: male gender at birth
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is a descriptive pilot study involving a population for which there are no data in the medical literature on which to base estimates of prevalence or incidence. Thus, prevalence will be expressed as percentage and seroconversions or new conditions as incidence per 100 people / year of follow-up. Exact 95% confidence intervals will be calculated.;Laboratory confirmed sexually transmitted infections | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactMauro Schechter
Projeto Praça Onze
Outcome results
None listed